ORIC Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibito…

Biotechnology
US, South San Francisco [HQ]

Income Statements

Loading...
End of ORIC's Analysis
CIK: 1796280 CUSIP: 68622P109 ISIN: US68622P1093 LEI: - UEI: -
Secondary Listings
ORIC has no secondary listings inside our databases.